By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — There’s potentially exciting news from a trial ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

The Trump administration is appealing the court order to reinstate grants and says it will fight “divisive DEI” in science.

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.

FULTON COUNTY, Ga. — Fulton County is set to receive more than $5 million in funding to combat the HIV epidemic, according to ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...